GSK plc (GSK)

Acerca de GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Al 3 de noviembre de 2026, la acción de GSK plc (GSK) retrocedió ligeramente a $48.91, una baja de 0.45% (-$0.22) frente al cierre anterior. En la sesión, las acciones han operado entre $48.84 y $49.56. Eso ubica a GSK en el tercio inferior de su rango de 52 semanas, de $45.81 a $61.70. GSK plc tiene una capitalización de mercado de aproximadamente $98.43 mil millones, con cerca de 1.47 millones de acciones negociadas.

Últimas noticias de GSK

• The U.S. Stocks Quietly Winning the Chinese Drug BoomYahoo Finance· 3 nov, 10:26 a.m. ET
• Buy Moderna Stock Before Q3 Earnings? Here's What to KnowYahoo Finance· 2 nov, 11:14 a.m. ET
• Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026Yahoo Finance· 2 nov, 8:00 a.m. ETPBC
• GSK (LSE:GSK) Wins FDA Nod For Jemperli As ESMO Data Builds Oncology CaseYahoo Finance· 1 nov, 6:15 a.m. ET
• GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?Yahoo Finance· 29 oct, 11:23 a.m. ET
• Chiesi Group appoints Paolo Paoletti to its Board of DirectorsYahoo Finance· 29 oct, 6:01 a.m. ET
• GSK (LSE:GSK) Shares Dropped, So What Is Behind The Latest Attention?Yahoo Finance· 29 oct, 4:23 a.m. ET
• Genmab Stock Surges to Record High After Stunning Cancer Drug ResultsYahoo Finance· 28 oct, 4:19 p.m. ET

Fuente: Yahoo Finance RSS · Actualizado el 3 de noviembre de 2026

¿Quieres titulares, alertas e investigación con IA de GSK en un solo lugar? Crea una cuenta gratis →

• $NVAX i wonder why $GSK doesnt buy Novavax flu/19 combo and doesn't develop their combo as the back up plan and make the money on the novavax combo meanwhile. because they are in phase 1 which will end next year. even if they should pay some minimal payment like $1.2B to n…

  @Pissed_of_retards2· 30 oct, 12:37 p.m. ET

• $SLS $GSK $HGSI I have been trading in the biotechnology sector for over 30 years now. My biggest hit in biotechnology sector was HGSI during the peak of financial collapse. HGSI was trading under a dollar left for dead and awaiting results for its phase 3 data for its Drug Be…

  @Johnmtnb2018· 30 oct, 11:19 a.m. ET· Alcista

• $GSK Suddenly GSK looks very attractive.

  @IndyOne· 30 oct, 6:09 a.m. ET· Alcista

• @Corona76ers fair point on Blenrep imo, that REMS for ocular toxicity is real and it is a separate myeloma drug. the one in this post is different, neladalkib is an ALK lung drug and the brain data is what caught my eye into Nov 27. 32% intracranial response in measurable brai…

  @BiotechSwings· 29 oct, 2:14 a.m. ET

• $GSK What is the cure for dementia worth these days? DOUBLE WOW, might make $MRNA look like child's play. And, I love Moderna. Fact check my posts from like October 2025 to August 2026. Looking for some place for Moderna money. This is one place. $MRK

  @IndyOne· 28 oct, 6:24 p.m. ET· Alcista

Fuente: Stocktwits. Las publicaciones de usuarios son opiniones, no hechos verificados. Ver lo que es tendencia →